laiv sdy
PDF Epidemiology of seasonal influenza in Hong Kong and use of seasonal ...
We observed lower effectiveness of LAIV compared with IIV against influenza A/H1N1pdm09 but not A(H3N2) or B among children and adolescents, suggesting poor performance related to the LAIV A/H1N1pdm09 viral construct. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. . Pediatrics.
news.gov.hk - Govt explains flu jab options - 香港政府新聞網
For live attenuated influenza vaccine (LAIV), overseas studies and clinical experience had generally indicated LAIV provides comparable protection against influenza to that afforded by inactivated influenza vaccine.
Types of seasonal influenza vaccine - World Health Organization (WHO)
Abstract. The USA has a long-standing paediatric influenza vaccination programme, including use of live attenuated influenza vaccine (LAIV). Following US evidence of apparent lack of vaccine effectiveness (VE) of LAIV in 2015/2016, particularly against A (H1N1)pdm09, the USA suspended the use of LAIV in the 2016/2017 season.
Defining the root cause of reduced H1N1 live attenuated ... - Nature
Menurut Organisasi Kesehatan Dunia , ada dua jenis vaksin influenza yang tersedia secara luas: yakni vaksin influenza yang dilemahkan (IIV) dan vaksin influenza hidup yang dilemahkan (LAIV). Secara tradisional, vaksin influenza (IIV dan LAIV) telah diproduksi untuk melindungi dari 3 virus influenza musiman yang berbeda (juga disebut vaksin ...
PDF Seasonal Influenza Vaccination - Centre for Health Protection
Hong Kong residents who wish to receive LAIV may from December 22 receive LAIV via private doctors/clinics participating in the Vaccination Subsidy Scheme (VSS) and the above-mentioned special arrangement (including private doctors/clinics coordinated by the Home Affairs Department) on a first-come-first-served basis.
Effectiveness of the quadrivalent live attenuated influenza vaccine ...
LAIV vaccinations consisted of a temperature-sensitive (ts) attenuated variant of HK/Syd, HK/Syd att/ts (LAIV) that contains site-specific mutations in the PB1 and PB2 RNA segments of the genome (see Fig. S1 in the supplemental material) as described previously .